Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells

Histone deacetylase inhibitors (HDACi) represent a promising class of epigenetic agents with anticancer properties. Here, we report that (S)-2, a novel hydroxamate-based HDACi, shown previously to be effective against acute myeloid leukemia cells, was also a potent inducer of apoptosis/differentiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurenzana, Anna, Balliu, Manjola, Cellai, Cristina, Romanelli, Maria Novella, Paoletti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587597/
https://www.ncbi.nlm.nih.gov/pubmed/23469273
http://dx.doi.org/10.1371/journal.pone.0058267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587597/
https://www.ncbi.nlm.nih.gov/pubmed/23469273
http://dx.doi.org/10.1371/journal.pone.0058267

Ejemplares similares